IMMUNKONJUGATE AUS EIDOTTER-ANTIKÖRPERN (IGY), DEREN KONFEKTIONIERUNG UND ANWENDUNG IN DIAGNOSTIK UND THERAPIE
    1.
    发明授权
    IMMUNKONJUGATE AUS EIDOTTER-ANTIKÖRPERN (IGY), DEREN KONFEKTIONIERUNG UND ANWENDUNG IN DIAGNOSTIK UND THERAPIE 有权
    IMMUNKONJUGATE AUS EIDOTTER-ANTIKÖRPERN(IGY),DEREN KONFEKTIONIERUNG UND ANWENDUNG在诊断和治疗中

    公开(公告)号:EP1387701B1

    公开(公告)日:2004-10-27

    申请号:EP02735057.8

    申请日:2002-05-03

    摘要: The invention relates to immunoconjugates made of egg-yolk antibodies (IgY), the production and use thereof in diagnoses and therapy. The aim of the invention is to provide alternative products to traditional immunoconjugates for use in diagnoses and therapy. The inventive immunoconjugates are superior to monoclonal antibodies and immune serums from mammals in addition to IgY preparations from conventional hens in terms of purity and antigen targeting. The invention seeks to avoid the formation of human anti-IgY antibodies as far as possible, and to produce immunoconjugates in large quantities at a low price in a manner which is compatible with animal welfare. This is achieved by polyclonal IgY conjugates from intact egg-yolk antibodies (IgY), IgY fragments, Fab constructions or humanized egg-yolk antibodies form SPF hens, preferably from transgenic SPF hens. The antibodies or antibody fragments are conjugated as immunologically effective components with at least one other component such as a signaling substance, an active substance or an amplifier module.

    摘要翻译: 本发明涉及由蛋黄抗体(IgY)制成的免疫缀合物,其在诊断和治疗中的生产和用途。 本发明的目的是提供用于诊断和治疗的传统免疫缀合物的替代产品。 就纯度和抗原靶向而言,除了来自传统母鸡的IgY制剂外,本发明的免疫缀合物优于来自哺乳动物的单克隆抗体和免疫血清。 本发明试图尽可能避免形成人抗IgY抗体,并且以与动物福利相容的方式以低价大量生产免疫缀合物。 这通过来自完整蛋黄抗体(IgY),IgY片段,Fab构建体或人源化蛋黄抗体的多克隆IgY缀合物形成SPF母鸡,优选来自转基因SPF母鸡。 抗体或抗体片段作为免疫学有效成分与至少一种其他组分例如信号物质,活性物质或放大器模块缀合。